%PDF-1.4
%
573 0 obj
<>
endobj
572 0 obj
<>stream
PScript5.dll Version 5.2.2
2024-03-28T11:03:43-07:00
2020-08-04T16:07:52-07:00
2024-03-28T11:03:43-07:00
application/pdf
First-in-Human Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Administrator
Acrobat Distiller 8.1.0 (Windows)
uuid:82b5c17d-1dd2-11b2-0a00-380827fd5800
uuid:82b5c180-1dd2-11b2-0a00-6a0000000000
endstream
endobj
571 0 obj
<>
endobj
5 0 obj
<>
endobj
2 0 obj
<>
endobj
22 0 obj
<>
endobj
23 0 obj
<>
endobj
62 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
63 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
64 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
65 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
66 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
67 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
68 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
594 0 obj
[597 0 R]
endobj
595 0 obj
<>stream
HWmo6n].l"%ѲS$M(}XmC*,~"U%ZQ$x/j8eEWco<_9|s|byrS<ҌͿ:\>jG\~f g?H:Ǥ8]Yrsi=.:zX'ݺR?W
mq
3g31C8^)*\~k-Ls+c4WHs^2%{+t>jNHȫ=H(1a#%r"| 5slR:65o&}IƆGuZJ;XEictܡUfH)s(o}ܤZڐAK3ޝV:54 ;u^
]To'ZP'
~$!.?יeȁX8Շ<VL~>d>QrAXI#%"˻i=N݃v#\16E.́iĄ_
s>adm\;wSS Om/6×\"*k+ # ә̝bK`po0@V2BbpDtIxenAKtW˾24-
~i~FWhijڠ-8w(Q0[/C+'1NVжkvhτ'g':D_sUȿόC;fyJSn}
a&櫍-~eհ'rZTc!G8'ECo(!%-ڍA:\<5)ҭW>#hGK?aG@nQw
O47 v#whyT]<jk2_\gDꅕ?fx.9!)+k-=idir"1+xKopؑ /f0w,BۯM~%pNzCk
ww,:z?̹˛m} jv]~Le4Exw<7љg[ȨL%I)H,dGm/eqn^ |8Mq1a5D@,!)Bj*:K4Upj-ssdW$N&ŀ-O%b̀q5 )ݐ.#x$i$˲5s*S:Ml,4G~Ou^s% ff:JJTMK]dvFpzf㯜̽"\8=)D oSqMoK6G:aQ*X1eQUͶ>ju\Ue/?qWo5;oq/#<DC=Ŗ=YbUջ,>Uv펬IpB5^ߗU5d=>T7e
{`7nX\gpwPʚJaU$,Skp6/'LW`fph